Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Systemic Lupus Erythematosus
Clinical trial register · Brazil

Systemic Lupus Erythematosus Trials in Brazil, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2233 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2233
Studies in scope
all four open statuses
1129
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
São Paulo 13 Porto Alegre 11 Salvador 11 Juiz de Fora 8 Curitiba 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
GlaxoSmithKline3 Hoffmann-La Roche2 Bristol-Myers Squibb2 Novartis Pharmaceuticals2 AstraZeneca2 Boehringer Ingelheim1 Sanofi1 Beeline Medicines Corporation1 AbbVie1 Federal University of Maranhao1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 University of Sao Paulo General Hospital1
Site location
São Paulo13 Porto Alegre11 Salvador11 Juiz de Fora8 Curitiba7 Belo Horizonte7 São José do Rio Preto5 Vitória4 Ribeirão Preto3 São Bernardo do Campo3 Niterói3 Cuiabá3 Rio de Janeiro3 Campinas2 Barretos2 Valinhos1 Curtiba1 Brasília1 Cuiab1 Ribeiro Preto1 Lago Sul1 Lajeado1 Porto Velho1 Fortaleza1 Recife1 Passo Fundo1 São Luís1 Graça1 Moinhos de Vento1 São José1
All 30 locations
Target enrolment
to

Systemic Lupus Erythematosus trials in Brazil

18 of 2233 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Not yet open
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis
NCT07493655Systemic Lupus Erythematosus, Lupus Nephritis, Drug Monitoring, Mycophenolic Acid
Federal University of Maranhao
Not applicable
100
São Luís
2026-07-01
Recruiting
Hoffmann-La Roche
Phase 2
30
Salvador, Brasília, Cuiab, Niterói, Porto Alegre, Ribeiro Preto, São Paulo
2026-05-25
Recruiting
Boehringer Ingelheim
Phase 2
405
Curitiba, Juiz de Fora, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Valinhos
2026-04-20
Recruiting
GlaxoSmithKline
Phase 1
44
Campinas, São Paulo
2026-02-10
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558Rheumatoid Arthritis, Systemic Lupus Erythematosus
DrugSurovatamig
AstraZeneca
Phase 1
48
Porto Alegre, Salvador, São Paulo
2025-12-02
Recruiting
GlaxoSmithKline
Phase 1
142
Porto Alegre, Juiz de Fora, Salvador
2024-09-02
Active, closed
GlaxoSmithKline
Phase 4
302
Belo Horizonte, São José do Rio Preto, Cuiabá, Juiz de Fora, Passo Fundo, Porto Alegre, Salvador, São Paulo
2024-06-06
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Vitória, Salvador, Belo Horizonte, Curitiba, Niterói, Rio de Janeiro, Barretos, São Paulo
2024-05-21
Recruiting
AstraZeneca
Phase 3
100
Belo Horizonte, Porto Alegre, Ribeirão Preto, São Paulo
2024-03-14
Active, closed
AbbVie
Phase 3
1,014
Vitória, Salvador, Juiz de Fora, Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2023-07-25
Active, closed
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
NCT05879419Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Systemic Lupus Erythematosus
DrugsRecombinant Herpes Zoster Vaccine·Shingrix
University of Sao Paulo General Hospital
Phase 4
2,005
São Paulo
2023-05-23
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Fortaleza, Vitória, Salvador, Belo Horizonte, Curitiba, Recife, Niterói, Rio de Janeiro
2023-03-02
Active, closed
Bristol-Myers Squibb
Phase 3
516
Salvador, Lago Sul, Belo Horizonte, Juiz de Fora, Curitiba, Porto Alegre, Campinas, Ribeirão Preto
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
513
Vitória, Lajeado, Porto Alegre, Porto Velho, Barretos, São Bernardo do Campo, Rio de Janeiro, São Paulo
2023-01-12
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 2
381
Belo Horizonte, Cuiabá, Graça, Juiz de Fora, Moinhos de Vento, São José, São Paulo
2022-09-16
Active, closed
Sanofi
Phase 2
109
Curitiba, Porto Alegre, São José do Rio Preto, São Paulo
2021-11-10
Active, closed
Hoffmann-La Roche
Phase 3
303
Salvador, Belo Horizonte, Juiz de Fora, Curtiba, Ribeirão Preto, São Bernardo do Campo
2021-10-26
Active, closed
Beeline Medicines Corporation
Phase 2
248
Salvador, Cuiabá, Juiz de Fora, Curitiba, Porto Alegre, São Bernardo do Campo, São José do Rio Preto, São Paulo
2021-10-11
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-brazil/condition/systemic-lupus-erythematosus

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,233 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies listing the condition Systemic Lupus Erythematosus.

How many Systemic Lupus Erythematosus trials are recruiting in Brazil?

7 of the 18 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Systemic Lupus Erythematosus), 18 studies
PhaseStudiesRecruitingShare
Phase 37238.9%
Phase 25227.8%
Phase 13316.7%
Phase 42011.1%
Not applicable105.6%

Most active sponsors

Lead sponsors with the most studies (Systemic Lupus Erythematosus)
Lead sponsorStudiesRecruiting
GlaxoSmithKline32
AstraZeneca22
Bristol-Myers Squibb20
Hoffmann-La Roche21
Novartis Pharmaceuticals21
AbbVie10
Beeline Medicines Corporation10
Boehringer Ingelheim11
Federal University of Maranhao10
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.